Cargando…

The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis

OBJECTIVE: The debate pertaining to the association between Keratoconus (KC) and Mitral Valve Prolapse (MVP) continues to occur among physicians. The results of cross-sectional studies attempting to present the co-existing prevalence of these two diseases remain indeterminate. We compiled the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Siordia, Juan A., Franco, Jimena C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460702/
https://www.ncbi.nlm.nih.gov/pubmed/31782369
http://dx.doi.org/10.2174/1573403X15666191129100928
_version_ 1783576663110451200
author Siordia, Juan A.
Franco, Jimena C.
author_facet Siordia, Juan A.
Franco, Jimena C.
author_sort Siordia, Juan A.
collection PubMed
description OBJECTIVE: The debate pertaining to the association between Keratoconus (KC) and Mitral Valve Prolapse (MVP) continues to occur among physicians. The results of cross-sectional studies attempting to present the co-existing prevalence of these two diseases remain indeterminate. We compiled the first meta-analysis to determine the pattern of prevalence between the two diseases. METHODS: Two separate literature searches for cross-sectional studies were performed for this meta-analysis. The first search encompassed finding literature comparing the prevalence of KC between patients with MVP and a control group. The second search pertained to finding studies comparing the prevalence of MVP patients with KC and a control group. RESULTS: Six studies reported the prevalence of MVP in patients with KC and a control group. The prevalence was 41.6% in patients with KC and 11.5% in patients without KC (OR = 7.06 [95% CI = 2.41-20.64]). There was a significant heterogeneity among the studies (I(2) = 84%). Two studies showed the prevalence of KC in patients with MVP and a control group. The prevalence was 17.0% in patients with KC and 2.9% in the control group (OR = 5.07 [95% CI = 1.08-23.83]). There was no heterogeneity within the analysis (I(2) = 0%). CONCLUSION: There is a statistically significant co-existing prevalence between MVP and KC. Patients with KC are more likely to present with MVP, and patients with MVP are more likely to present with KC.
format Online
Article
Text
id pubmed-7460702
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-74607022021-05-01 The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis Siordia, Juan A. Franco, Jimena C. Curr Cardiol Rev Article OBJECTIVE: The debate pertaining to the association between Keratoconus (KC) and Mitral Valve Prolapse (MVP) continues to occur among physicians. The results of cross-sectional studies attempting to present the co-existing prevalence of these two diseases remain indeterminate. We compiled the first meta-analysis to determine the pattern of prevalence between the two diseases. METHODS: Two separate literature searches for cross-sectional studies were performed for this meta-analysis. The first search encompassed finding literature comparing the prevalence of KC between patients with MVP and a control group. The second search pertained to finding studies comparing the prevalence of MVP patients with KC and a control group. RESULTS: Six studies reported the prevalence of MVP in patients with KC and a control group. The prevalence was 41.6% in patients with KC and 11.5% in patients without KC (OR = 7.06 [95% CI = 2.41-20.64]). There was a significant heterogeneity among the studies (I(2) = 84%). Two studies showed the prevalence of KC in patients with MVP and a control group. The prevalence was 17.0% in patients with KC and 2.9% in the control group (OR = 5.07 [95% CI = 1.08-23.83]). There was no heterogeneity within the analysis (I(2) = 0%). CONCLUSION: There is a statistically significant co-existing prevalence between MVP and KC. Patients with KC are more likely to present with MVP, and patients with MVP are more likely to present with KC. Bentham Science Publishers 2020-05 2020-05 /pmc/articles/PMC7460702/ /pubmed/31782369 http://dx.doi.org/10.2174/1573403X15666191129100928 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Siordia, Juan A.
Franco, Jimena C.
The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis
title The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis
title_full The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis
title_fullStr The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis
title_full_unstemmed The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis
title_short The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis
title_sort association between keratoconus and mitral valve prolapse: a meta-analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460702/
https://www.ncbi.nlm.nih.gov/pubmed/31782369
http://dx.doi.org/10.2174/1573403X15666191129100928
work_keys_str_mv AT siordiajuana theassociationbetweenkeratoconusandmitralvalveprolapseametaanalysis
AT francojimenac theassociationbetweenkeratoconusandmitralvalveprolapseametaanalysis
AT siordiajuana associationbetweenkeratoconusandmitralvalveprolapseametaanalysis
AT francojimenac associationbetweenkeratoconusandmitralvalveprolapseametaanalysis